This site is intended for healthcare professionals

account_circleSign in
Go to /sign-in page

You can view 5 more pages before signing in

Sulphasalazine and ulcerative colitis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Sulphasalazine is metabolised by colonic bacteria and azo-reduction to produce sulpha (sulphahydrine) and salicylate moities (5-aminosalicylic acid, 5-ASA) in the colonic lumen (1)

Various points have been noted about the usefulness of sulphasalazine:

  • sulphasalazine and 5-ASA have been found to be therapeutically equivalent (2)

  • the efficacy of sulphasalazine is limited by substantial dose-related intolerance in addition to allergic and toxic reactions to the sulpha component

  • sulphasalazine is commonly used in those patients with concomitant joint disease (2)

Reference:

  • Azad Khan AK,Piris J,Truelove SC (1977). An experiment to determine the active therapeutic moiety of sulphasalazine, Lancet, 2, 892-5.
  • Prescriber (2001), 12 (20), 43-58.

Related pages

Create an account to add page annotations

Create a free account

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page